Support teaching, research, and patient care.
My scholarly research over the past 25 years has focused on understanding autistic symptoms in children with neurogenetic disorders such as fragile X syndrome, Cornelia de Lange syndrome and Prader-Willi syndrome to determine how environmental and biological factors affect the development of these behaviors, toward the goal of creating patient-specific treatments. My investigations include state-of-the-art eye tracking, functional assessments of behavior under controlled experimental conditions, neuroimaging, and novel behavioral and pharmacological interventions. I am extensively trained in behavioral assessment and interventions, and provide clinical evaluations and consultation as a doctoral-level Board Certified Behavior Analyst (BCBA-D). Given that many children and families experience difficulties accessing in-person care, I am particularly interested in developing targeted treatments that can be delivered via telehealth.
My primary area of scholarly and clinical interest is the pathogenesis of problem behaviors shown by individuals diagnosed with intellectual and developmental disabilities (IDD), particularly those with neurogenetic forms of IDD, such as fragile X syndrome, Cornelia de Lange syndrome and Prader-Willi syndrome. My work aims to both advance understanding of these disorders and to identify effective new treatment approaches for pediatric and adult patient populations by state-of-the-art methodologies, such as brain imaging, eye tracking and functional analysis to determine how environmental and biological factors affect the development of aberrant behaviors in these syndromes. The end goal of my research is to create patient-specific methods for treating the symptoms of these disorders.
Telehealth-Enabled Versus In-Person Parent-Mediated Behavioral Treatment for Challenging Behaviors in Children With ASD
The purpose of the research is to determine whether parent-mediated behavior therapy for
challenging behavior commonly displayed by children with autism spectrum disorder (ASD) can
be as effective when delivered via telehealth as when delivered in-person.
Stanford is currently not accepting patients for this trial.
For more information, please contact Scott Hall, PhD, 650-498-4799.
View full details